Hyaluronic Acid
NDC Package 77651-4162-6

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Hyaluronic Acid is a . Marketed by Quimfa S.a, this product is identified by NDC 77651-4162 and is authorized under FDA application ANDA076559.

Identification & Billing

NDC Package Code
77651-4162-6
Package Description
1 INJECTION in 1 SYRINGE
Product Code
77651-4162
11-Digit Billing Format
77651416206

Clinical Specifications

Proprietary Name
Hyaluronic Acid
Dosage Form
-

Regulatory & Marketing

Labeler Name
Quimfa S.a
FDA Application #
ANDA076559
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-06-2002
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 77651-4162-6 identifies a specific commercial package of 1 injection in 1 syringe of Hyaluronic Acid, labeled by Quimfa S.a. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Quimfa S.a on December 06, 2002. The current certification is valid through December 31, 2021.

How is this Quimfa S.a product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 77651416206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
77651-4162-6
11-Digit CMS (5-4-2)
77651-4162-06

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.